中华普通外科学文献(电子版)
中華普通外科學文獻(電子版)
중화보통외과학문헌(전자판)
CHINESE JOURNAL OF GENERAL SURGERY(ELECTRONIC VERSION)
2014年
6期
441-445
,共5页
张洛%冯笑山%李青%欧阳范献%林志刚%陈成辉%潘在用
張洛%馮笑山%李青%歐暘範獻%林誌剛%陳成輝%潘在用
장락%풍소산%리청%구양범헌%림지강%진성휘%반재용
贲门癌%淋巴结%微转移%高/低发病区
賁門癌%淋巴結%微轉移%高/低髮病區
분문암%림파결%미전이%고/저발병구
Gastric cardia adenocarcinoma%Lymph node%Micrometastases%High and low incidence areas
目的探讨贲门癌高、低发病区淋巴结微转移的特点。方法采用免疫组织化学方法,用细胞角蛋白19(CK19)单抗和CD44v6单抗分别检测海南省农垦总医院(低发区组,48例)和河南科技大学第一附属医院(高发区组,45例)贲门癌患者常规病理学检查阴性的淋巴结微转移情况,并结合临床病理资料进行统计学分析。结果共24例(25.81%)47枚(6.99%)淋巴结存在微转移,低、高发区两组淋巴结微转移阳性率的差异有统计学意义(4.33%vs 9.46%,χ2=6.763,P=0.009),两组的临床重新分期率差异无统计学意义(18.75%vs 33.33%,χ2=2.576,P=0.108)。87例获随访,两组淋巴结微转移阳性者的复发率均明显高于微转移阴性者(P<0.05);生存率均明显低于微转移阴性者(P<0.05)。组间比较,高发区组的复发率低于低发区组(19.05%vs 35.56%,χ2=3.986,P=0.046)。结论不论在贲门癌高、低发病区均有必要监测淋巴结微转移。贲门癌淋巴结微转移阳性者复发和死亡率高。
目的探討賁門癌高、低髮病區淋巴結微轉移的特點。方法採用免疫組織化學方法,用細胞角蛋白19(CK19)單抗和CD44v6單抗分彆檢測海南省農墾總醫院(低髮區組,48例)和河南科技大學第一附屬醫院(高髮區組,45例)賁門癌患者常規病理學檢查陰性的淋巴結微轉移情況,併結閤臨床病理資料進行統計學分析。結果共24例(25.81%)47枚(6.99%)淋巴結存在微轉移,低、高髮區兩組淋巴結微轉移暘性率的差異有統計學意義(4.33%vs 9.46%,χ2=6.763,P=0.009),兩組的臨床重新分期率差異無統計學意義(18.75%vs 33.33%,χ2=2.576,P=0.108)。87例穫隨訪,兩組淋巴結微轉移暘性者的複髮率均明顯高于微轉移陰性者(P<0.05);生存率均明顯低于微轉移陰性者(P<0.05)。組間比較,高髮區組的複髮率低于低髮區組(19.05%vs 35.56%,χ2=3.986,P=0.046)。結論不論在賁門癌高、低髮病區均有必要鑑測淋巴結微轉移。賁門癌淋巴結微轉移暘性者複髮和死亡率高。
목적탐토분문암고、저발병구림파결미전이적특점。방법채용면역조직화학방법,용세포각단백19(CK19)단항화CD44v6단항분별검측해남성농은총의원(저발구조,48례)화하남과기대학제일부속의원(고발구조,45례)분문암환자상규병이학검사음성적림파결미전이정황,병결합림상병리자료진행통계학분석。결과공24례(25.81%)47매(6.99%)림파결존재미전이,저、고발구량조림파결미전이양성솔적차이유통계학의의(4.33%vs 9.46%,χ2=6.763,P=0.009),량조적림상중신분기솔차이무통계학의의(18.75%vs 33.33%,χ2=2.576,P=0.108)。87례획수방,량조림파결미전이양성자적복발솔균명현고우미전이음성자(P<0.05);생존솔균명현저우미전이음성자(P<0.05)。조간비교,고발구조적복발솔저우저발구조(19.05%vs 35.56%,χ2=3.986,P=0.046)。결론불론재분문암고、저발병구균유필요감측림파결미전이。분문암림파결미전이양성자복발화사망솔고。
Objective To investigate lymph nodes micrometastases characteristics in gastric cardia adenocarcinoma(GCA) from the high and low incidence area in China. Methods Lymph nodes of patients with GCA were obtained from Hainan Provincial Nongken General Hospital (low incidence area group, 48 cases) and the First Affiliated Hospital of Henan University of Science and Technology (high incidence area group, 45 cases). Micrometastases were detected by immunohistochemical staining for the markers cytokeratin 19(CK19) and CD44 variant 6(CD44v6). The data were analyzed statistically. Results A total of 47 lymph nodes micrometastases (6.99%) from 24 patients (25.81%) were found out. The incidence of lymph nodes micrometastases was significantly different between the two groups (4.33%vs 9.46%,χ2=6.763, P=0.009). Clinical re-staging had no significant difference in the two groups (18.75%vs 33.33%,χ2=2.576, P=0.108). 87 patients were followed up, and the recurrence rate was significantly higher and survival rate was significantly lower in the positive group than in those without lymph node micrometastases (P<0.05). Recurrence rate was significantly lower in patients from the high incidence area than from the low incidence area (19.05%vs 35.56%,χ2=3.986, P=0.046). Conclusion Detecting micrometastases is necessary in GCA patients, whether from the high or low incidence. Micrometastases might correlate with worse prognosis for patients of GCA.